Core Viewpoint - dsm-firmenich has announced the divestment of its Animal Nutrition & Health (ANH) activities to CVC Capital Partners, leading to a reclassification of the financial results of ANH as Discontinued Operations and the assets and liabilities as Assets Held for Sale [1][2]. Financial Results and Reporting Structure - The financial results have been restated to present the Continuing Operations of dsm-firmenich, ensuring a comparable view of the company's ongoing performance over time, with full-year 2025 results to be reported on February 12, 2026 [2]. - Comparative figures for the most recent four reported quarters (Q4 2024, Q1 2025, Q2 2025, Q3 2025) and full-year 2024 will include line items such as Net Sales, Adjusted EBITDA, Adjusted EBITDA margin, and Organic Sales Growth [3]. - The new reporting structure reflects primary structural adjustments for 2024 and 2025, particularly in the Perfumery & Beauty (P&B) segment, which has been restated for Aroma Ingredients and Pentapharm, now included in Discontinued Operations [4]. Segment Adjustments - The Taste, Texture & Health (TTH) segment has been restated primarily for Yeast Extracts and certain vitamin sales included in the ANH divestment, which have moved to Discontinued Operations, while Bovaer has been transferred from ANH to TTH [5]. - The Health, Nutrition & Care (HNC) segment has been restated for Marine Lipids and certain vitamin sales included in the ANH divestment, with Veramaris being transferred from ANH to HNC [6]. - Discontinued Operations now include ANH, Aroma Ingredients, Marine Lipids, Yeast Extracts, and certain vitamin sales, following a portfolio review communicated at the Capital Markets Day in 2024 [7]. Key Performance Indicator (KPI) Adjustments - dsm-firmenich will provide an updated 'Core EBIT' figure, which adds back merger-related amortization and amortization of other intangible assets recognized through purchase-price allocations from all pre-merger acquisitions, facilitating easier comparison with industry peers [8]. Future Reporting Adjustments - The Nutrition Improvement activities, focusing on sustainability-driven nutritional support and food aid programs, will transfer from Health, Nutrition & Care to Group Sustainability and will be reported under Corporate Activities starting Q1 2026, generating approximately €20 million in quarterly net sales [10].